Potential for prevention of inhibitor formation by immune tolerance

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 2, 2000, Pages 173-178

  Kaplan, Joseph ^a   Genyea, Carol ^a   Secord, Elizabeth ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

DNA vaccines; Factor VIII inhibitors; Immune tolerance; Oral tolerance; Recombinant human factor VIII

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 DERIVATIVE; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 8; ALLOANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; CLONE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HEMOPHILIA A; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; ANIMAL; HUMAN; IMMUNOLOGY; NEWBORN; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; INFANT, NEWBORN; ISOANTIBODIES;

EID: 0033643654     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9820     Document Type: Review

References (34)

1. 1. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 1988;318:947-950
2. 2. Gruppo RA, Valdez LP, Stout RD. Induction of immune tolerance in patients with hemophilia A and inhibitors. Am J Pediatr Hematol Oncol 1992;14:82-87
3. 3. Kreuz W, Becker S, Lenz E, et al. Factor VIII inhibitors in patients with hemophilia A: Epidemiology of inhibitor development and induction of immune tolerance for factor VIII. Semin Thromb Hemost 1995;21:382-389
4. 4. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors - twenty years' "Bonn Protocol." Vox Sang 1996;70(suppl 1):30-35
5. 5. Rocino A, de Biasi R. Successful immune tolerance treatment with monoclonal or recombinant factor VIII concentrates in high responding inhibitor patients. Vox Sang 1999;77(suppl S1):65-69
6. 6. Connelly S, Andrews JL, Gallo AM, et al. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 1998;91:3273-3281
7. 7. Burnett FM, Fenner F. The Production of Antibodies, 2nd ed. London: Macmillan; 1949:102-105
8. 8. Owen RD. Immunogenic consequences of vascular anastomoses between bovine twins. Science 1945;102:400-401
9. 9. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172:603-606
10. 10. Triplett EL. On the mechanism of immunologic self recognition. J Immunol 1962;89:505-510
11. 11. Hultin MB. Acquired inhibitors in malignant and nonmalignant disease states. Am J Med 1991;91:9S-13S
12. 12. Gill FM. The natural history of factor VIII inhibitors in patients with hemophilia A. In: Hoyer LW, ed. Factor VIII Inhibitors, New York: Liss; 1984:19-29
13. 13. Schwaab R, Brackmann HH, Meyer C, et al. Haemophilia mutation type determines risk of inhibitor formation. Thromb Haemost 1995;74:1402-1406
14. 14. Peerlinck K, Jacquemin MG, Arnout J, et al. Anti-factor VIII antibody inhibiting hemophilia A. Blood 1999;93:2267-2273
15. 15. Aly AM, Aledort LM, Lee TD, Hoyer LW. Antibodies. Histocompatibility antigen patterns in haemophilic patients with factor VIII. Br J Haematol 1990;76:238-241
16. 16. Hay CR, Ollier W, Pepper L, et al. HLA class II profile: A weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost 1997;77:234-237
17. 17. Oldenburg J, Picard JK, Schwaab R, et al. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997;77:238-242
18. 18. Ohta H, Takahashi I, Kojima T, et al. Histocompatibility antigens and alleles in Japanese haemophilia A patients with or without factor VIII antibodies. Tissue Antigens 1999;54:91-97
19. 19. Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy JM. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J Clin Invest 1996;97:1382-1388
20. 20. Cinader B. Immunogencity and tolerance to autologous macromolecules. In: Cinader B, ed. Regulation of the Antibody Response. Springfield, IL: Charles C Thomas; 1968:3-53
21. 21. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen induced arthritis by intragastric administration of soluable type II collagen. Proc Natl Acad Sci U S A 1986;83:7443-7446
22. 22. Klinman DM, Takeno M, Ichino M, et al. DNA vaccines: Safety and efficacy issues. Springer Semin Immunopathol 1997;19: 245-256
23. 23. Strobel SL. Neonatal oral tolerance. Ann NY Acad Sci 1996; 778:88-102
24. 24. Hanson DG. Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns. J Immunol 1981;127:1518-1524
25. 25. Troncone R, Ferguson A. In mice, gluten in maternal diet primes systemic immune responses to gliadin in offspring. Immunology 1988;64:533-537
26. 26. Brown W, Le M, Lee E. Induction of systemic immunologic hyporesponsiveness to ovalbumin in neonatal rats by the enteric administration of peptic fragments of ovalbumin. Immunol Invest 1994;23:73-83
27. 27. Velander WH, Lee TK, Scandella DH, et al. Transgenic pigs produce functional human factor VIII in milk. Nat Biotechnol 1997;15:971-975
28. 28. Cowdery JS, Curtin MF Jr, Steinberg AD. Effect of prior intragastric antigen administration on primary and secondary anti-ovalbumin responses of C57BL/6 and NZB mice. J Exp Med 1982;156:1256-1261
29. 29. Lafont S, Andre C, Andre F, Gillon J, Fargier MC. Abrogation by subsequent feeding of antibody response including IgE, in parenterally immunized mice. J Exp Med 1982;155:1573-1578
30. 30. Mor G, Yamshchikov G, Sedegah M, et al. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest 1996;98:2700-2705
31. 31. Ichino M, Mor G, Conover J, et al. Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. J Immunol 1999;162:3814-3818
32. 32. Bot A, Antohi S, Bot S, Garcia-Sastre A, Bona C. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int Immunol 1997;9:1641-1650
33. 33. Manickan E, Yu Z, Rouse BT. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J Clin Invest 1997;100:2371-2375
34. 34. Wang Y, Xiang Z, Pasquini S, Ertl HC. Immune response to neonatal genetic immunization. Virology 1997;228:278-284.